BIOLASE, INC Annual Income Tax Expense (Benefit) in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Biolase, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Biolase, Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $20K, a 35.5% decline year-over-year.
- Biolase, Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $38K, a 62.4% decline year-over-year.
- Biolase, Inc annual Income Tax Expense (Benefit) for 2023 was $31K, a 71.6% decline from 2022.
- Biolase, Inc annual Income Tax Expense (Benefit) for 2022 was $109K, a 67.7% increase from 2021.
- Biolase, Inc annual Income Tax Expense (Benefit) for 2021 was $65K, a 49.2% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)